Company registration number 13470700 (England and Wales)
MYHEALTHCARE (SERVICES) LIMITED
FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
PAGES FOR FILING WITH REGISTRAR
MYHEALTHCARE (SERVICES) LIMITED
CONTENTS
Page
Balance sheet
1
Statement of changes in equity
2
Notes to the financial statements
3 - 6
MYHEALTHCARE (SERVICES) LIMITED
BALANCE SHEET
AS AT
31 DECEMBER 2025
31 December 2025
- 1 -
2025
2024
Notes
£
£
£
£
Intangible assets
-
0
-
0
Current assets
Debtors
4
40,311
40,311
Creditors: amounts falling due within one year
5
(1,250)
-
0
Net current assets
39,061
40,311
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
38,961
40,211
Total equity
39,061
40,311

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 26 March 2026 and are signed on its behalf by:
Mr B Patel
Director
Company registration number 13470700 (England and Wales)
MYHEALTHCARE (SERVICES) LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2025
- 2 -
Share capital
Profit and loss reserves
Total
£
£
£
Balance at 1 January 2024
100
40,211
40,311
Year ended 31 December 2024:
Profit and total comprehensive income
-
-
0
-
0
Balance at 31 December 2024
100
40,211
40,311
Year ended 31 December 2025:
Loss and total comprehensive income
-
(1,250)
(1,250)
Balance at 31 December 2025
100
38,961
39,061
MYHEALTHCARE (SERVICES) LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
- 3 -
1
Accounting policies
Company information

MYHEALTHCARE (SERVICES) LIMITED is a private company limited by shares incorporated in England and Wales. The registered office is 18 Fitzhardinge Street, London, W1H 6EQ.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the equirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view. As the company is not a going concern, other than going concern basis of accounting has been applied as stated below.

The financial statements have been prepared on other than going concern basis at the period end. In adopting the these basis at the year end the following policies and procedures were implemented.

- all assets have been disclosed at values at which they are expected to be realised

- all liabilities reflect the full amount at which they are expected to materialise

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The company has taken advantage of the exemption under section 399 of the Companies Act 2006 not to prepare consolidated accounts, on the basis that the group of which this is the parent qualifies as a small group. The financial statements present information about the company as an individual entity and not about its group.

1.2
Going concern

The directors consider it inappropriate to prepare the financial statements on a going concern basis and therefore the directors have prepared these financial statements on other than going concern basis.

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

The nature, timing of satisfaction of performance obligations and significant payment terms of the company's major sources of revenue are as follows:

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that are recover able.

MYHEALTHCARE (SERVICES) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 4 -
1.3
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.4
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. A m ounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.5
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

MYHEALTHCARE (SERVICES) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 5 -
1.6
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

Critical judgements

The following judgements (apart from those involving estimates) have had the most significant effect on amounts recognised in the financial statements.

Critical judgements in applying the Company's accounting policies

During the year, the Directors have concluded that there were no critical accounting judgements.

Key sources of estimation uncertainty

During the year, there were no key sources of estimation uncertainty.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
4
4
4
Debtors
2025
2024
Amounts falling due within one year:
£
£
Other debtors
3,755
4,366
MYHEALTHCARE (SERVICES) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
4
Debtors
(Continued)
- 6 -
2025
2024
Amounts falling due after more than one year:
£
£
Amounts owed by group undertakings
36,556
35,945
Total debtors
40,311
40,311
5
Creditors: amounts falling due within one year
2025
2024
£
£
Other creditors
1,250
-
0
6
Audit report information

As the income statement has been omitted from the filing copy of the financial statements, the following information in relation to the audit report on the statutory financial statements is provided in accordance with s444(5B) of the Companies Act 2006.

The auditor's report is unqualified and includes the following:

Opinion

In our opinion the financial statements:

- give a true and fair view of the state of the company's affairs as at 31 December 2025 and of its loss for the year then ended;

- have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and

- have been prepared in accordance with the requirements of the Companies Act 2006.

Senior Statutory Auditor:
Yashlal Hindocha BA,FCA
Statutory Auditor:
Hindocha & Co Limited
Date of audit report:
26 March 2026
7
Related party transactions

Included in debtors an amount of £35,556 (2024 - £35,945) money due from My H ealthcare Clinic L td, the immediate parent company.

8
Parent company

The controlling party is Horizon Global (Healthcare) Ltd. The company and its ultimate parent company undertakings are under the control of Mr B Patel and family.

2025-12-31 2025-01-01 false false false 26 March 2026 CCH Software CCH Accounts Production 2025.300 No description of principal activity Dr A Patel Dr S Patel Mr D Gunasekera Mr B Patel 13470700 2025-01-01 2025-12-31 13470700 2025-12-31 13470700 2024-12-31 13470700 core:CurrentFinancialInstruments 2025-12-31 13470700 core:CurrentFinancialInstruments 2024-12-31 13470700 core:ShareCapital 2025-12-31 13470700 core:ShareCapital 2024-12-31 13470700 core:RetainedEarningsAccumulatedLosses 2025-12-31 13470700 core:RetainedEarningsAccumulatedLosses 2024-12-31 13470700 core:ShareCapital 2023-12-31 13470700 core:RetainedEarningsAccumulatedLosses 2023-12-31 13470700 bus:Director4 2025-01-01 2025-12-31 13470700 core:RetainedEarningsAccumulatedLosses 2024-01-01 2024-12-31 13470700 2024-01-01 2024-12-31 13470700 core:RetainedEarningsAccumulatedLosses 2025-01-01 2025-12-31 13470700 core:CurrentFinancialInstruments core:WithinOneYear 2025-12-31 13470700 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 13470700 core:Non-currentFinancialInstruments 2025-12-31 13470700 core:Non-currentFinancialInstruments 2024-12-31 13470700 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 13470700 bus:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 13470700 bus:FRS102 2025-01-01 2025-12-31 13470700 bus:Audited 2025-01-01 2025-12-31 13470700 bus:Director1 2025-01-01 2025-12-31 13470700 bus:Director2 2025-01-01 2025-12-31 13470700 bus:Director3 2025-01-01 2025-12-31 13470700 bus:FullAccounts 2025-01-01 2025-12-31 xbrli:pure xbrli:shares iso4217:GBP